Stockholders' Equity and Convertible Preferred Stock (Tables)

12 Months Ended

Dec. 31, 2019

Stockholders' Equity Note [Abstract]

Schedule of designated separate series of capital stock

The Company had designated separate series of its capital stock as of December 31, 2019 and December 31, 2018 as summarized below:

	Number of Shares Issued
	and Outstanding as of
	December 31, 2019		December 31, 2018		Par Value		Conversion Ratio
Series "A"		—		—	$	0.0001	N/A
Series "C"		—		—		0.0001	0.05:1
Series "D"		4,725		4,725		0.0001	0.53:1
Series "D-1"		834		834		0.0001	0.53:1
Series "F-1"		—		—		0.0001	0.05:1
Series "H"		—		—		0.0001	0.53:1
Series "I"		—		—		0.0001	1.05:1
Series "J"		—		—		0.0001	0.05:1
Series "K"		—		—		0.0001	263.16:1

Schedule of warrant activity

A summary of warrant activity for year ended December 31, 2019 and 2018 is presented below:

	Warrants			Weighted Average Exercise Price		Total Intrinsic Value		Weighted Average Remaining Contractual Life (in years)
Outstanding as of December 31, 2018		294,072		$	38.15	$	-		1.92
Issued		301,960			-		506,273		-
Exercised		(235,294	)		-		394,940		-
Expired		(8,799	)		476.66		-		-
Outstanding as of December 31, 2019		351,939		$	19.96		111,332		0.94

Schedule of fair value of options granted

	For the Years Ended December 31,
	2019	2018
Exercise price	-	$1.04 - $1.50
Term (years)	-	9.13 - 9.34
Expected stock price volatility	-	131.8% - 132.2%
Risk-free rate of interest	-	2.65% - 2.80%

Schedule of option activity

A summary of option activity under the Company's stock option plan for year ended December 31, 2019 and 2018 is presented below:

	Number of Shares			Weighted Average Exercise Price		Total Intrinsic Value		Weighted Average Remaining Contractual Life (in years)
Outstanding as of December 31, 2018		124,381		$	209.22	$	-		4.8
Employee options expired		(35,121	)		302.29		-		-
Non-employee options expired		(310	)		571.71		-		-
Outstanding as of December 31, 2019		88,950		$	172.39	$	-		5.7
Options vested and exercisable		88,950		$	172.39	$	-		5.7